Arkolith/Insider Trading/DNLI/Form 4

Sato Vicki L

DirectorDenali Therapeutics Inc. (DNLI) · full profile →Form 4 · filed Sep 4, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$77K
Net Open-Market Flow
-$77K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 3, 2024Sell(S)3K$24.99$74K116K
Sep 3, 2024Sell(S)100$25.37$3K116K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001714899-24-000198) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML